Paramagnetic dysprosium oxide nanoparticles and dysprosium hydroxide nanorods as T 2 MRI contrast agents

Biomaterials

Volumn 33, Issue 11, 2012, Pages 3254-3261

  Kattel, Krishna ^a   Park, Ja Young ^a   Xu, Wenlong ^a   Kim, Han Gyeol ^a   Lee, Eun Jung ^a   Bony, Badrul Alam ^a   Heo, Woo Choul ^a   Jin, Seonguk ^b   Baeck, Jong Su ^b   Chang, Yongmin ^b   Kim, Tae Jeong ^a   Bae, Ji Eun ^a   Chae, Kwon Seok ^a   Lee, Gang Ho ^a  

^a Kyungpook National University   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

Author keywords

Dysprosium; Imaging agent; MRI; Nanomaterials; Paramagnetic

Indexed keywords

4F-ELECTRONS; APPLIED FIELD; CONTRAST ENHANCEMENT; D-GLUCURONIC ACID; DYSPROSIUM OXIDE; HYDRODYNAMIC DIAMETER; IMAGING AGENT; IN-VITRO; IN-VIVO; MOUSE LIVER; MR IMAGES; MR IMAGING; MRI CONTRAST AGENTS; PARAMAGNETIC; RENAL EXCRETION; ROOM TEMPERATURE; S STATE; ULTRA-SMALL;

GLUCOSE; MAGNETIC PROPERTIES; MAGNETIC RESONANCE IMAGING; NANOPARTICLES; NANORODS; NANOSTRUCTURED MATERIALS; PARAMAGNETIC MATERIALS; PARAMAGNETISM;

DYSPROSIUM;

DYSPROSIUM; DYSPROSIUM HYDROXIDE; DYSPROSIUM OXIDE; GLUCURONIC ACID; NANOMATERIAL; NANOPARTICLE; NANOROD; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; PROTON; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CRYSTAL STRUCTURE; CRYSTALLIZATION; CYTOTOXICITY; HUMAN; HUMAN CELL; HYDRODYNAMICS; IMAGE ANALYSIS; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; ONE POT SYNTHESIS; PARTICLE SIZE; PHYSICAL CAPACITY; PRIORITY JOURNAL; ROOM TEMPERATURE;

ANIMALS; CONTRAST MEDIA; DYSPROSIUM; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MALE; MICE; MICE, INBRED ICR; OXIDES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84862792767     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.01.008     Document Type: Article

References (37)

1. Lauffer R.B. Paramagnetic metal complexes as water proton relaxation agents for NMR imaging: theory and design. Chem Rev 1987, 87:901-927.
2. Caravan P., Ellison J.J., McMurry T.J., Lauffer R.B. Gadolinium(III) chelates as MRI contrast agents: structure, dynamics, and applications. Chem Rev 1999, 99:2293-2352.
3. Roch A., Muller R.N., Gillis P. Theory of proton relaxation induced by superparamagnetic particles. JChem Phys 1999, 110(11):5403-5411.
4. Bridot J.L., Faure A.C., Laurent S., Rivière C., Billotey C., Hiba B., et al. Hybrid gadolinium oxide nanoparticles: multimodal contrast agents for invivo imaging. JAm Chem Soc 2007, 129:5076-5084.
5. 1 MR images. ACS Nano 2009, 3(11):3663-3669.
6. 1 MR images, and account for relaxivities. ACS Appl Mater Interf 2010, 2(10):2949-2955.
7. Cotton F.A., Wilkinson G. Advanced inorganic chemistry 1980, John Wiley & Sons, New York, pp. 983-985.
8. Lal H.B., Pratap V., Kumar A. Magnetic susceptibility of heavy rare-earth sesquioxides. Pramana 1978, 10(4):409-412.
9. Wolf W.P., Meissner H., Catanese C.A. Magnetic properties of rare earth hydroxides. JAppl Phys 1968, 39(2):1134-1136.
10. Eliseeva S.V., Bünzli J.C.G. Lanthanide luminescence for functional materials and bio-sciences. Chem Soc Rev 2010, 39:189-227.
11. Bünzli J.C.G. Lanthanide luminescence for biomedical analyses and imaging. Chem Rev 2010, 110:2729-2755.
12. Wang G., Peng Q., Li Y. Lanthanide-doped nanocrystals: synthesis, optical-magnetic properties, and applications. Acc Chem Res 2011, 44(5):322-332.
13. Jung C.W., Jacobs P. Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. Magn Reson Imaging 1995, 13(5):661-674.
14. Sorensen C.M. Magnetism. Nanoscale materials in chemistry 2001, 215-216. Wiley-Interscience, New York. K.J. Klabunde (Ed.).
15. 3 nanoparticles for optimal performance as an MRI contrast agent. JAm Chem Soc 2008, 130:5335-5340.
16. Norek M., Pereira G.A., Geraldes C.F.G.C., Denkova A., Zhou W., Peters J.A. NMR transversal relaxivity of suspensions of lanthanide oxide nanoparticles. JPhys Chem C 2007, 111:10240-10246.
17. Gossuin Y., Hocq A., Vuong Q.L., Disch S., Hermann R.P., Gillis P. Physico-chemical and NMR relaxometric characterization of gadolinium hydroxide and dysprosium oxide nanoparticles. Nanotechnology 2008, 19:475102. (8 pages).
18. 3+ nanocrystals as dual-modal contrast agent for high field magnetic resonance and optical imaging. Chem Mater 2011, 23:2439-2446.
19. 3 (Ln= Eu, Gd, Dy, Ho, and Er) nanoparticles as a new potential MRI contrast agent. ACS Appl Mater Interfaces 2011, 3(9):3325-3334.
20. JCPDS File No. 43-1006 for Dy2O3 and JCPDS File No. 19-0430 for Dy(OH)3. International Center for Diffraction Data. PCPDFWIN v. 1.30, 1997.
21. 3 nanocrystals functionalised by organic acids. JColloids Interface Sci 2005, 288:140-148.
22. 6 dicarboxylic acids at pH= 5.0. Geochim Cosmochim Acta 2001, 65(23):4289-4301.
23. Hug S.J., Bahnemann D. Infrared spectra of oxalate, malonate and succinate adsorbed on the aqueous surface of rutile, anatase and lepidocrocite measured with in situ ATR-FTIR. JElectron Spectro Relat Phenomena 2006, 150:208-219.
24. 2 in the aqueous phase. Langmuir 1994, 10:3587-3597.
25. 2. Phys Chem Chem Phys 2006, 8:3232-3247.
26. Li Y., Ooi C.P., Cheang P.H.N., Khor K.A. Synthesis and characterization of neodymium(III) and gadolinium(III)-substituted hydroxyapatite as biomaterials. Int J Appl Ceram Technol 2009, 6(4):501-512.
27. 3 nanorods. Physica B 2011, 406:1639-1644.
28. Stefanakis D., Ghanotakis D.F. Synthesis and characterization of gadolinium nanostructured materials with potential applications in magnetic resonance imaging, neutron-capture therapy and targeted drug delivery. JNanopart Res 2010, 12:1285-1297.
29. Hemmer E., Kohl Y., Colquhoun V., Thielecke H., Soga K., Mathur S. Probing cytotoxicity of gadolinium hydroxide nanostructures. JPhys Chem B 2010, 114:4358-4365.
30. 3 nanorod and nanotube precursors and self-templates produced by a microwave-assisted hydrothermal process. CrystEngComm 2010, 12:2952-2966.
31. 3. Int J Chem Kinet 2007, 39:75-81.
32. Corbierre M.K., Cameron N.S., Lennox R.B. Polymer-stabilized gold nanoparticles with high grafting densities. Langmuir 2004, 20:2867-2873.
33. Weast R.C. CRC handbook of chemistry and physics 1984-1985, CRC Press, Inc., Boca Raton, p. B-95. 65th ed.
34. Arajs S., Colvin R.V. Magnetic susceptibility of gadolinium and dysprosium sesquioxides at elevated temperatures. JAppl Phys 1962, 33(8):2517-2519.
35. Reimer P., Balzer T. Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications. Eur Radiol 2003, 13:1266-1276.
36. Lawaczek R., Menzel M., Pietsch H. Superparamagnetic iron oxide particles: contrast media for magnetic resonance imaging. Appl Organometal Chem 2004, 18:506-513.
37. Weissleder R., Elizondo G., Wittenberg J., Rabito C.A., Bengele H.H., Josephson L. Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. Radiology 1990, 175:489-493.